TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pathological locoregional complete tumor response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of PF-07328948 Tablet Formation and Oral Suspension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time 0 to the Time of the Last Quantifiable Concentration (AUClast) of PF-07328948 Tablet Formation and Oral Suspension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of systolic blood pressure, diastolic blood pressure and mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Level of heart rate and respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Level of pulse oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Salivary plasma drug concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with high grade prostate cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Operative Delivery Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Gastric astral cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality adjusted overall survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of tissue biopsies obtained from treated patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of research specimens obtained before RT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of research specimens obtained after RT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of research specimens obtained at the time of surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Worsening of Daily Passive Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening of Daily Active Suicidal Ideation
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in the Probability of Daily Suicidal Planning
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to Tolerate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acceptability as Measured by FACT Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of secure attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attendance at musical training sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Bladder diary data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dose-Limiting Toxicities rate (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Any Medically-attended Adverse Events (MAAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph node metastasis status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 14-3-3 eta protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Days Illicit Opioids Used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rest-of-day blood glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average change in central foveal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity at Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity at Intermediate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity at Near
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in PC20 After Each Treatment Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Verbal Rating Scales of food craving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional, biological, and esthetic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of bleeding during preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken during preparation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Color change assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in blue autofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pap smear result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: postoperative consumption of opioids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolomic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Work-related mental fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Work-related burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence of preoperative respiratory adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Orthostatic Hypotension Questionnaire (OHQ)/Orthostatic Intolerance Questionnaire (OIQ) Composite Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum Troponin I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Procedure time in hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency, duration, and intensity of solicited local adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency, duration, and intensity of solicited systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Serious Adverse Events (SAEs), Medically Attended Adverse Events (MAAEs), Adverse Events of Special Interest and any AEs leading to study withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titres (GMT) of the serum NAb titres to matched SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroresponse rate (SRR) to matched SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NRS Numeric rating scale for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Örebro Musculoskeletal Pain Screening Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keele STarT Back Screening Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low Back Outcome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center for Epidemiological Studies-Depression Scale (CES-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive and affective empathy test
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interpersonal reactivity index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Empathic Understanding of Relationship Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Expressed Empathy Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Patient Health Questionnaire 9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Worsened pulmonary function test (PFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of acantholytic cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with positive reaction to cold testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients without mobile teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with negative reaction to palpation testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with negative reaction to percussion testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with periodontal probing depths within normal limits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients without clinical signs of inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration versus time curve from time zero to last time point (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration versus time curve from time zero to infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in center of pressure location under the foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious adverse event and reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Unexpected adverse reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Suspected unexpected serious adverse reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with BKV-related nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean absorbed dose (Gy) for the whole body
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absorbed dose (Gy) for critical non-liver organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective dose (Gy) for the whole body
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of endometrial cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of endometrial hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with visual axis opacification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of participants with uveitis and iris/pupil abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of knee bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Portal Vein Pulsatility Index (PVPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Improved CARS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity and specificity of GHS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TASC-2 scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of research sites recruiting patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients recruited in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of studies implemented through the network
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Anthropometry Z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of near pathological complete response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgeon safety
Endpoint domain: Adverse events/effects
Primary endpoint: Immunohistochemical expression of ALDOA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Adverse events related to exercise
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Euro-qol 5 Question-5 Dimension -5 Level (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients satisfied with their participation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on participant quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Impact on quality of sexual life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intervention Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sessions Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Survey Completion at 1 Month
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on quality of life questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Desirability in outcome ranking (DOOR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: telomere length of the first Polar body
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: telomere length in Cumulus cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Widespread Pain Index (WPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean HbA1c (NGSP%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of time adequate sedation depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood sugar fasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood sugar random
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HbA1c: Glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Presence of evolocumab in surgical tumor tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Performance of the devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the devices
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects with negative conversion of HBsAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Edema after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of antibodies in pregnant women 1 month after vaccination with Tdap
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of antibodies to all Tdap-IPV and Hexavalent antigens in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abnormal uterine bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Experience of the disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aspirations regarding the future
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Level of physical activity short-term
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of physical activity medium-term
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Level of physical activity long-term
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensation of shortness of breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sagittal condylar guidance angle during protrusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical height of the temporomandibular joint fossa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sagittal condylar guidance angle on Cone Beam Computed Tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Features of the incisors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface refractive index shifts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe post-resection bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freedom from target lesion failure (TLF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erythema and melanin content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of maximally tolerated dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Type and incidence of adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: change in plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on Extracellular vesicles number
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on anxiety, depression and stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emergency department discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: COVID-19 progression
Endpoint domain: Mortality/survival
Primary endpoint: Wong-Baker FACES Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diet Quality Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma Nitrite Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motor scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of ataxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Incidence and severity of AE/SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Stabilization of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-hospital and 28-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: TLF at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tel-me-box adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ARV Hair concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Movement Assessment (GMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screening Hand Assessment for Infants (SHAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in transepidermal water loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean change from baseline in skin redness by Chromameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes from baseline in local SCORAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Patients Without Disease Progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plantar Flexors Muscle Oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who had a sexual health discussion
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cmax of ethionamide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of ethionamide-sulfoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ethionamide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of ethionamide-sulfoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Score of Acute Physiology and Chronic Health Evaluation II (APACHE II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hooper and Mackinnon Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vertical and Horizontal Jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1RM, Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in probing pocket depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in proportion of periodontal pocket closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restoration of regular menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Needle placement efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Virologic suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reducing tumor growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes